Position in CYTK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$479,364
+$87,530 QoQ
Shares Held
5,627
-5.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#311
of 477 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 35%
Shared 0%
None 65%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026COLDSTREAM CAPITAL MANAGEMENT INC holds $14,996,603 across 23 Biotechnology names. CYTK ranks #10 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,151 | $3,055,385 | |
| 2 | TECH |
BIO-TECHNE Corp
|
36,070 | $2,548,345 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
3,849 | $927,493 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,384 | $862,979 | |
| 5 | OMER |
Omeros Corp
|
84,743 | $805,905 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
8,635 | $675,861 | |
| 7 | MRNA |
Moderna, Inc.
|
9,260 | $648,477 | |
| 8 | INCY |
Incyte Corp
|
4,536 | $514,200 |
All Filings in CYTK
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $479,364 | 5,627 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $391,834 | 5,945 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $338,032 | 5,320 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $261,169 | 4,752 | Shares | Sole | 2025-11-19 | |
| 2025-03-31 | $115,305 | 2,869 | Shares | Sole | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||